- Association Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use and Blood Pressure Levels in Nondiabetic Obese Adults: A Cross-Sectional Analysis
Cureus · 2026
- Dapagliflozin associates with heart rate variability decline in T2DM patients on GLP-1 receptor agonist therapy: a prospective observational study
Frontiers in Endocrinology · 2026
- Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?
Current Hypertension Reports · 2026
- Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis
Archives of Pharmacal Research · 2026
- Efficacy of SGLT2i and GLP-1RA in Acute Myocardial Infarction: AMeta-Analysis of Randomized Controlled Trials
Current Medicinal Chemistry · 2026
- Cardiometabolic Health: The Missing Piece in Most Cardiovascular Evaluations
2026
- Cardiometabolic Health: The Missing Piece in Most Cardiovascular Evaluations
2026
- A Case of GLP-1 Receptor Agonist-Induced Lithium Neurotoxicity
Journal of Psychiatric Practice · 2026
- Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study)
Clinical Therapeutics · 2026
- 0984 Do Glucagon-Like Peptide-1 Agonists Improve Sleep? Evidence from a Nationally Representative Sample of Adults in the United States
SLEEP · 2026
- GLP-1 receptor agonists improve and preserve microvascular endothelial function - Focus on chemotherapy induced vascular damage
Physiology · 2026
- Perioperative anesthesia and aspiration-related outcomes in patients receiving GLP-1 receptor agonists undergoing urgent and elective procedures: a systematic review
Trends in Anaesthesia and Critical Care · 2026
- A65-06 Glucagon-Like Peptide-1 Receptor Agonist Use in Patients With Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine · 2026
- Exploration of the Effects of SGLT-2 Inhibitors and GLP-1 Receptor Agonists on Coronary Inflammation in Type 2 Diabetes Patients Based on the Peri-Coronary Fat Attenuation Index.
2026
- Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study
Diabetes and Vascular Disease Research · 2026
- "Divergent Efficacy of GLP-1 Receptor Agonists in HFpEF Versus HFrEF: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".
2026
- GLP-1 and Parkinson’s Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy
Cells · 2026
- Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists: A systematic review
American Journal of Health-System Pharmacy · 2026
- GLP-1 Receptor Activation and Cardioprotection: Mechanisms and Clinical Implications
2026
- Metabolic and Bariatric Surgery vs Glucagon-like peptide-1 Receptor Agonist Therapy
Annals of Surgery · 2026
- Efficacy of GLP-1 receptor agonists in Parkinson’s disease: a systematic review and exploratory network meta-analysis of randomized controlled trials
Neurological Sciences · 2026
- Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study
Diabetes Obesity and Metabolism · 2026
- Potential Effect of the Short-Acting GLP-1 Agonist Exenatide on Copeptin in Healthy Adults
Obesity and Endocrinology · 2026
- Association Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Atrial Fibrillation Adverse Events: A Systematic Review and Meta-Analysis of Randomized Trials
Cureus · 2026
- Glucagon-Like Peptide-1 Receptor Agonists in Patients with Heart Failure with Reduced Ejection Fraction
ESC Heart Failure · 2026
- Estimated Glomerular Filtration Rate Change and Heart Failure Events With <scp>GLP</scp> ‐1 Receptor Agonists: A Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials
Diabetes Obesity and Metabolism · 2026
- Beyond Monotherapy: The Superior Efficacy of Combined <scp>GLP</scp> ‐1 Receptor Agonist and <scp>SGLT2</scp> Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2026
- Preoperative GLP-1 Receptor Agonist Use and Postoperative Outcomes in Orthopaedic Surgery: A Scoping Review of Perioperative and Recovery Outcomes
Journal of the American Academy of Orthopaedic Surgeons · 2026
- GLP-1 Receptor Agonists in Acute Ischemic Stroke and Secondary Stroke Prevention: A Narrative Review of Preclinical and Clinical Evidence
Journal of Central Nervous System Disease · 2026
- A-118 | Glucagon-Like Peptide-1 Receptor Agonists and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction and Mitral Regurgitation: A Real-World Analysis
Journal of the Society for Cardiovascular Angiography & Interventions · 2026
- C-104 | Comparative Outcomes of Left Bundle Branch Area Pacing and Biventricular Pacing in Heart Failure With Reduced Ejection Fraction- Meta-analysis
Journal of the Society for Cardiovascular Angiography & Interventions · 2026
- Neonatal and Obstetric Outcomes Following Periconceptional Exposure to Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-analysis
American Journal of Obstetrics and Gynecology · 2026
- Balancing Clinical and Ethical Considerations Related to Placebo Use in Trials of Incretin-Based Therapies in Heart Failure
Journal of the American College of Cardiology · 2026
- Target Trial Emulation: Glucagon-Like Peptide 1 Receptor Agonist, Sodium-Glucose Cotransporter-2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors for Kidney Outcome Prevention
Clinical Journal of the American Society of Nephrology · 2026
- Perioperative and Renal Outcomes After Nephrectomy in Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists: A Pilot Study
Urology Practice · 2026
- Association of GLP-1 Receptor Agonists Versus Bariatric Surgery with Outcomes in Obese Patients with Hypertrophic Cardiomyopathy: A Multicenter Propensity-Matched Analysis
European Heart Journal - Quality of Care and Clinical Outcomes · 2026
- Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit
Circulation Heart Failure · 2026
- Efficacy and Safety of Glucagon‐Like Peptide 1 Receptor Agonists in Parkinson Disease: A Systematic Review and Meta‐Analysis
Brain and Behavior · 2026
- Clinical outcomes of glucagon-like peptide-1 receptor agonist therapy in kidney transplant recipients: a systematic review and meta-analysis
Clinical Kidney Journal · 2026
- Abstract WE444: Prevalence and Predictors of GLP-1 Receptor Agonist Use Among U.S. Adults with Diabetes: Findings from the National Health Interview Survey, 2024
Circulation · 2026
- Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review
Diabetes Therapy · 2026
- Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study
The Lancet Psychiatry · 2026
- Exploring the Pleiotropic Cardioprotective Effects of GLP-1 Receptor Agonists in Preventing Anthracycline-Induced Cardiotoxicity: A Theoretical Proposal for Future Research
Medicines · 2026
- Systematic Review Evaluating the Effects of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use on the Postoperative Outcomes of Patients Undergoing Arthroplasty Procedures
Cureus · 2026
- Weight Loss in Primary Total Hip and Knee Arthroplasty: A Comparative Study of Glucagon-Like Peptide-1 Receptor Agonists and Bariatric Surgery
Arthroplasty Today · 2026
- Real‐World Cardiovascular Outcomes of <scp>GLP</scp> ‐1 Receptor Agonists in Women With Type 2 Diabetes and Breast Cancer
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2026
- <scp>GLP</scp> ‐1 Receptor Agonists Versus Bariatric Surgery: Effects of Weight Loss and <scp>BMI</scp> on Subsequent General Surgical Procedures
Clinical Obesity · 2026
- Glucagon-like peptide-1 receptor agonists in rheumatoid arthritis
Current Opinion in Rheumatology · 2026
- Preoperative GLP-1 Receptor Agonist Use and Weight Loss Outcomes Following Bariatric Surgery
Annals of Surgery · 2026
- A new era in reducing obesity and the risk of cardiovascular disease events in preeclampsia
Journal of Hypertension · 2026